SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (748)5/15/1997 5:27:00 PM
From: BadMan   of 6136
 
Rick & Tommysdad
Sorry Rick, for the provocative statements about Viracept. Things have been building-up inside of me. I just had to vent some steam!!!!!

Tommysdad, in statement#2 I did not mean that AGPH was flying solo.
Japan Tobacco did provide the necessary $$$$$ but IMO they could not help with FDA validation. Even the mighty CHIR could not help CEPH when dealing with FDA. That is what I was refering to: pushing drugs through the dreaded FDA Hoopla. Your other point is well taken.
Yes, 2 to 3 years down the road Viracept maybe the second or third option for treatment of HIV, but by that time AGPH's cancer drug will be on the market, which in turn will generate a ton of $$$$$$$$.

Best of luck to the both of you

Andrew
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext